1Mao P, Wang S, Wang S, et al. Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti - lymphocyte globulin and cylcophosphamide as conditioning therapy. Bone Marrow Transplant,2004,33(1) : 33 -38.
3Maciejewski JP, Sloand EM, Nunez O, et al. Recombinant humanized anti - IL - 2 receptor antibody (daclimmab) produces responses in patients with moderate aplastic anemia. Blood, 2003, 102(10) :3584 - 3586.
4Maciejewski JP, Rivera C, Kook H, et al. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol -anchored protein - deficient clones. Br J Haematol, 2001,115(4) :1015 - 1022.
5Choudhry VP, Gupta S, Gupta M,et al. Pregnancy associated aplastic anemia - a series of 10 cases with review of literature, Hematology, 2002, 7(4) :233 -238.
6Maciejewski JP, Follmann D, Nakamura R, et al. Increased frequency of HLA - DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome. Blood, 2001,98( 13 ) :3513 -3519.
7Kook H, Risitano AM, Zeng W, et al. Changes in T - cell receptor Vβ repertoire in aplastic anemia: effects of different immunosuppressire regimens. Blood, 2002, 99(10) :3668-3675.
8Risitano AM, Kook H, Zeng W, et al. Oligoclonal and polyclonal CD4 and CDs lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDB3 spectratyping and flow cytometry. Blood, 2002, 100(1) :178 -183.
9Risitano AM, Msciejewski JP, Green S, et al. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T- cell clones by TCR beta- CDB3 sequencing.Lancet, 2004, 364(9431 ):355-364.
10Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomomse reverse transcriptase, in aplastic anemia. N Engl J Med, 2005, 352(14) :1413 -1424.
二级参考文献15
1Young NS. Acquired aplastic anemia. Ann Intern Med, 2002,136:534-546.
2Dufour C, Corcione A, Svahn J, et al. Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia.Br J Haematol, 2001,115:1023-1031.
3Xu JL, Nagasaka T, Nakashima N. Involvement of cytotoxic granules in the apoptosis of aplastic anaemia.Br J Haematol,2003,120:850-852.
4Kaito K, Otsubo H, Usui N, et al. Th1/Th2 lymphocyte balance in patients with aplastic anemia. Rinsho Byori, 2004,52:569-573.
5Giannakoulas NC, Karakantza M, Theodorou GL, et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients.Br J Haematol, 2004,124:97-105.
6Kaito K, Otsubo H, Ogasawara Y, et al.Severe aplastic anemia associated with chronic natural killer cell lymphocytosis. Int J Hematol, 2000,72:463-465.
7Sun R, Wei H, Zhang J, et al. The effects of natural killer-cell depletion on ex vivo expansion of hematopoietic progenitor cells from umbilical cord blood. Haematologica, 2003,88:561-569.
8Zeng W, Maciejewski JP, Chen G, et al. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.Br J Haematol, 2002,119:803-809.
9Hara T, Ando K, Tsurumi H, et al. Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia. Eur J Haematol, 2004,73:10-16.
10Maciejewski JP, Sloand EM, Nunez O, et al. Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood, 2003,102:3584-3586.
